TY - JOUR
T1 - Phosphatidylethanol Levels in Postpartum Women and Their Newborns in Uruguay and Brazil
AU - Baldwin, Aileen E.
AU - Hayes, Nicole
AU - Ostrander, Erika
AU - Magri, Raquel
AU - Sass, Nelson
AU - dos Anjos Mesquita, Maria
AU - Martínez, Monica
AU - Juliani, Monica Correa
AU - Cabral, Pablo
AU - Fleming, Michael
N1 - Funding Information:
This study was funded by NIH NIAAA grant U01‐AA0231.
Funding Information:
There is no conflict of interest from any of the authors. While the first author is employed by the laboratory that performed the PEth testing 100% of the funds used for this study came from the NIAAA grant that supported this work. In addition, Dr Baldwin has no personal financial interest in the USDTL laboratory.
Publisher Copyright:
© 2020 by the Research Society on Alcoholism
PY - 2020/6/1
Y1 - 2020/6/1
N2 - Background: There is increasing interest in the development of newborn screening tests to identify children at risk of fetal alcohol spectrum disorder (FASD) in order to provide these children with early intervention. Phosphatidylethanol (PEth) has emerged as a potential universal newborn screening candidate. Methods: The aim of this report was to present the results of a study designed to compare PEth levels in 1,140 postpartum women and their newborn infants in Montevideo, Uruguay, and Sao Paulo, Brazil. Self-report alcohol use during pregnancy data was collected, along with both maternal and newborn dried blood spot samples for PEth analysis. Results: The average age and parity of the women in the sample were 26 years of age and 2.3 pregnancies. For the Uruguay sample (n = 611), 45.8% of postpartum women had PEth levels ≥ 8 ng/ml with a mean positive PEth of 43.6 ng/ml. In contrast, 86.8% of the newborns had PEth levels ≥ 8 ng/ml, with a mean positive PEth of 77.4 ng/ml. For the Brazil sample (n = 529), 33.2% of women had PEth levels ≥ 8 ng/ml with a mean positive PEth of 31 ng/ml. In contrast, 76.9% of the Brazil newborns had PEth levels ≥ 8 ng/ml and 43.9% with a mean positive PEth of 61.1 ng/ml. PEth levels were significantly higher in newborns compared with their postpartum mothers in both the Uruguay and Brazil samples. Self-reported third-trimester alcohol was 6% in the Uruguay sample and 9.1% in the Brazil sample compared with positive maternal PEth levels in 45.8% and 33.2%, respectively. Conclusions: Clinicians may want to consider newborn PEth screening in high-risk populations where prenatal alcohol use is common. The mechanism underlying significantly higher PEth levels in newborns compared with their mothers is not known.
AB - Background: There is increasing interest in the development of newborn screening tests to identify children at risk of fetal alcohol spectrum disorder (FASD) in order to provide these children with early intervention. Phosphatidylethanol (PEth) has emerged as a potential universal newborn screening candidate. Methods: The aim of this report was to present the results of a study designed to compare PEth levels in 1,140 postpartum women and their newborn infants in Montevideo, Uruguay, and Sao Paulo, Brazil. Self-report alcohol use during pregnancy data was collected, along with both maternal and newborn dried blood spot samples for PEth analysis. Results: The average age and parity of the women in the sample were 26 years of age and 2.3 pregnancies. For the Uruguay sample (n = 611), 45.8% of postpartum women had PEth levels ≥ 8 ng/ml with a mean positive PEth of 43.6 ng/ml. In contrast, 86.8% of the newborns had PEth levels ≥ 8 ng/ml, with a mean positive PEth of 77.4 ng/ml. For the Brazil sample (n = 529), 33.2% of women had PEth levels ≥ 8 ng/ml with a mean positive PEth of 31 ng/ml. In contrast, 76.9% of the Brazil newborns had PEth levels ≥ 8 ng/ml and 43.9% with a mean positive PEth of 61.1 ng/ml. PEth levels were significantly higher in newborns compared with their postpartum mothers in both the Uruguay and Brazil samples. Self-reported third-trimester alcohol was 6% in the Uruguay sample and 9.1% in the Brazil sample compared with positive maternal PEth levels in 45.8% and 33.2%, respectively. Conclusions: Clinicians may want to consider newborn PEth screening in high-risk populations where prenatal alcohol use is common. The mechanism underlying significantly higher PEth levels in newborns compared with their mothers is not known.
KW - Biomarkers
KW - Fetal Alcohol Spectrum Disorders
KW - Phosphatidylethanol
KW - Prenatal Alcohol Exposure
KW - Screening
UR - http://www.scopus.com/inward/record.url?scp=85085183405&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85085183405&partnerID=8YFLogxK
U2 - 10.1111/acer.14339
DO - 10.1111/acer.14339
M3 - Article
C2 - 32441809
AN - SCOPUS:85085183405
SN - 0145-6008
VL - 44
SP - 1292
EP - 1299
JO - Alcoholism: Clinical and Experimental Research
JF - Alcoholism: Clinical and Experimental Research
IS - 6
ER -